The Emmes Company, LLC
Global clinical research organization integrating scientific services, technology, and AI to design, run, and analyze complex clinical trials across government, non-profit, and biopharma sponsors. Offers full-service clinical operations, biostatistics, data management, regulatory support, and a unified cloud eClinical platform with AI-driven orchestration and specimen tracking.
Industries
Nr. of Employees
Very Large (1000+)
The Emmes Company, LLC
Products
Advantage eClinical Cloud (unified eClinical platform)
Cloud-native unified eClinical platform built on a single CDISC-compliant database integrating EDC, eCOA/ePRO, RTSM, eConsent and reporting.
GlobalTrace (specimen tracking and inventory)
Purpose-built system for tracking biospecimens in real time, maintaining specimen attributes, transfer history, residual volume and consent linkage to clinical data.
Advantage eClinical Cloud (unified eClinical platform)
Cloud-native unified eClinical platform built on a single CDISC-compliant database integrating EDC, eCOA/ePRO, RTSM, eConsent and reporting.
GlobalTrace (specimen tracking and inventory)
Purpose-built system for tracking biospecimens in real time, maintaining specimen attributes, transfer history, residual volume and consent linkage to clinical data.
Services
Operational management for Phase I–IV trials including study start-up, site management and global operations.
Statistical design, analysis, automated TFL generation and AI-assisted CSR drafting.
End-to-end data capture, cleaning, query management, anomaly detection and database lock support.
Regulatory strategy and submission support for drugs, devices and biologics across jurisdictions.
Safety monitoring, signal detection and medical oversight throughout the trial lifecycle.
Provision of a unified cloud eClinical platform with integrations to EDC, CTMS, lab systems, and specimen tracking.
Operational management for Phase I–IV trials including study start-up, site management and global operations.
Statistical design, analysis, automated TFL generation and AI-assisted CSR drafting.
End-to-end data capture, cleaning, query management, anomaly detection and database lock support.
Regulatory strategy and submission support for drugs, devices and biologics across jurisdictions.
Safety monitoring, signal detection and medical oversight throughout the trial lifecycle.
Provision of a unified cloud eClinical platform with integrations to EDC, CTMS, lab systems, and specimen tracking.
Expertise Areas
- Clinical trial management
- Biostatistics and statistical programming
- Clinical data management
- AI-driven clinical automation and orchestration
Key Technologies
- Unified eClinical platform (EDC/eCOA/ePRO/RTSM/eConsent)
- AI operational agents for workflow orchestration
- Cloud-native infrastructure (AWS)
- Automated EDC form build from protocol metadata
News & Updates
Announcement of ISO/IEC 27001:2022 certification for information security management and ISO/IEC 27018:2019 for protection of personal data in the cloud.
Press release announcing initiation of a pivotal trial for a cellular therapy in partnership with a clinical trials network.
Announcement reorganizing the business and launching a technology and AI business unit to embed AI across clinical research operations.
CEO perspective on the role and adoption of AI and automation in clinical trials.
Reported metrics: 2,150+ Phase I–IV trials in 90+ countries; 32,000+ clinical trial sites; 434+ publications since 2016; 200+ SDTM studies; 1M+ trial participants.
Announcement of ISO/IEC 27001:2022 certification for information security management and ISO/IEC 27018:2019 for protection of personal data in the cloud.
Press release announcing initiation of a pivotal trial for a cellular therapy in partnership with a clinical trials network.
Announcement reorganizing the business and launching a technology and AI business unit to embed AI across clinical research operations.
CEO perspective on the role and adoption of AI and automation in clinical trials.
Reported metrics: 2,150+ Phase I–IV trials in 90+ countries; 32,000+ clinical trial sites; 434+ publications since 2016; 200+ SDTM studies; 1M+ trial participants.